Skip to main content
SpringerLink
Log in

Heterogeneity of the Precursor Lesions of Endometrial Carcinoma, According to the Histologic Subtype

  • Chapter
  • First Online:
Pathology of Female Cancers

  • 917 Accesses

Abstract

Endometrial carcinoma is a constellation of different types of carcinomas, each exhibiting different morphology, genetic abnormalities, and clinical outcomes and developing via a different carcinogenesis process. Atypical endometrial hyperplasia/endometrioid intraepithelial neoplasia (AEH/EIN) is a precursor of endometrioid carcinoma. AEH/EIN is a noninvasive proliferation of atypical epithelium, which frequently harbors mutations in the PTEN, KRAS, CTNNB1, or ARID1A genes that are observed in endometrioid carcinoma. Microsatellite instability caused by epigenetic suppression of DNA mismatch repair protein MLH1 is also observed in AEH/EIN. These genetic abnormalities constitute early events of endometrioid carcinogenesis. As serous carcinoma without stromal invasion shows aggressive behavior, noninvasive serous neoplasia is designated as serous endometrial intraepithelial carcinoma (SEIC). Mutation of TP53 is detected in most cases of serous carcinoma and SEIC. Mutation of TP53 occurs in normal-appearing epithelium and is designated as p53 signature. Some clear cell carcinomas have associated intraepithelial lesions exhibiting less atypia than carcinoma. Although this lesion is a putative precursor lesion of clear cell carcinoma, further study is necessary.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15:10–7.

    Article  CAS  PubMed  Google Scholar 

  2. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients. Cancer. 1985;56:403–12.

    Article  CAS  PubMed  Google Scholar 

  3. Bergeron C, Nogales FF, Masseroli M, Abeler V, Duvillard P, Müller-Holzner E, Pickartz H, Wells M. A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am J Surg Pathol. 1999;23:1102–8.

    Article  CAS  PubMed  Google Scholar 

  4. Zaino R, Carineli SG, Ellenson LH, Eng C, Katabuchi H, Konishi I, Lax S, Matias-Guiu X, Mutter GL, Peters WA III, Sherman ME, Shih I-M, Soslow R, Stewart CJR. Epithelial tumours and precursors. In: Kurman RJ, Carcangiu ML, Herrington CS, Young RJ, editors. WHO classification of tumours of female reproductive organs. 4th ed. Lyon: International Agency for Research on Cancer; 2014. p. 125–35.

    Google Scholar 

  5. Silverberg SG. Problems in the differential diagnosis of endometrial hyperplasia and carcinoma. Mod Pathol. 2000;13:309–27.

    Article  CAS  PubMed  Google Scholar 

  6. Kendall BS, Ronnett BM, Isacson C, Cho KR, Hedrick L, Diener-West M, Kurman RJ. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol. 1998;22:1012–9.

    Article  CAS  PubMed  Google Scholar 

  7. Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ II, Alberts D, Curtin J. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer. 2006;106:812–9.

    Article  PubMed  Google Scholar 

  8. Mutter GL. Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group. Gynecol Oncol. 2000;76:287–90.

    Article  CAS  PubMed  Google Scholar 

  9. Hecht JL, Ince TA, Baak JP, Baker HE, Ogden MW, Mutter GL. Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis. Mod Pathol. 2005;18:324–30.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Rakha E, Wong SC, Soomro I, Chaudry Z, Sharma A, Deen S, Chan S, Abu J, Nunns D, Williamson K, McGregor A, Hammond R, Brown L. Clinical outcome of atypical endometrial hyperplasia diagnosed on an endometrial biopsy: institutional experience and review of literature. Am J Surg Pathol. 2012;36:1683–90. https://doi.org/10.1097/PAS.0b013e31825dd4ff.

    Article  PubMed  Google Scholar 

  11. Baak JP, Mutter GL, Robboy S, van Diest PJ, Uyterlinde AM, Orbo A, Palazzo J, Fiane B, Løvslett K, Burger C, Voorhorst F, Verheijen RH. The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. Cancer. 2005;103:2304–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Sun H, Enomoto T, Fujita M, Wada H, Yoshino K, Ozaki K, Nakamura T, Murata Y. Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia. Am J Clin Pathol. 2001;115:32–8.

    Article  CAS  PubMed  Google Scholar 

  13. Hayes MP, Wang H, Espinal-Witter R, Douglas W, Solomon GJ, Baker SJ, Ellenson LH. PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia. Clin Cancer Res. 2006;12(20 Pt 1):5932–5.

    Article  CAS  PubMed  Google Scholar 

  14. Mutter GL, Ince TA, Baak JPA, Kust G, Zhou X, Eng C. Molecular identification of latent precancers in histologically normal endometrium. Cancer Res. 2001;61:4311–4.

    PubMed  CAS  Google Scholar 

  15. Berg A, Hoivik EA, Mjøs S, Holst F, Werner HM, Tangen IL, Taylor-Weiner A, Gibson WJ, Kusonmano K, Wik E, Trovik J, Halle MK, Øyan AM, Kalland KH, Cherniack AD, Beroukhim R, Stefansson I, Mills GB, Krakstad C, Salvesen HB. Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients. Oncotarget. 2015;6:1327–39. https://doi.org/10.18632/oncotarget.2675.

    Article  PubMed  Google Scholar 

  16. Konopka B, Janiec-Jankowska A, Kwiatkowska E, Najmoła U, Bidziński M, Olszewski W, Goluda C. PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors. Hum Pathol. 2011;42:1710–9. https://doi.org/10.1016/j.humpath.2010.01.030.

    Article  PubMed  CAS  Google Scholar 

  17. Mutter GL, Wada H, Faquin WC, Enomoto T. K-ras mutations appear in the premalignant phase of both microsatellite stable and unstable endometrial carcinogenesis. Mol Pathol. 1999;52:257–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Zauber P, Denehy TR, Taylor RR, Ongcapin EH, Marotta S, Sabbath-Solitare M. Strong correlation between molecular changes in endometrial carcinomas and concomitant hyperplasia. Int J Gynecol Cancer. 2015;25:863–8. https://doi.org/10.1097/IGC.0000000000000421.

    Article  PubMed  Google Scholar 

  19. Saegusa M, Hashimura M, Yoshida T, Okayasu I. β- catenin mutations and aberrant nuclear expression during endometrial tumorigenesis. Br J Cancer. 2001;84:209–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Moreno-Bueno G, Hardisson D, Sarrió D, Sánchez C, Cassia R, Prat J, Herman JG, Esteller M, Matías-Guiu X, Palacios J. Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia. J Pathol. 2003;199:471–8.

    Article  CAS  PubMed  Google Scholar 

  21. Wiegand KC, Lee AF, Al-Agha OM, Chow C, Kalloger SE, Scott DW, Steidl C, Wiseman SM, Gascoyne RD, Gilks B, Huntsman DG. Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas. J Pathol. 2011;224:328–33. https://doi.org/10.1002/path.2911.

    Article  PubMed  CAS  Google Scholar 

  22. Werner HM, Berg A, Wik E, Birkeland E, Krakstad C, Kusonmano K, Petersen K, Kalland KH, Oyan AM, Akslen LA, Trovik J, Salvesen HB. ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas. Mod Pathol. 2013;26:428–34. https://doi.org/10.1038/modpathol.2012.174.

    Article  PubMed  CAS  Google Scholar 

  23. Mao TL, Ardighieri L, Ayhan A, Kuo KT, Wu CH, Wang TL, Shih IM. Loss of ARID1A expression correlates with stages of tumor progression in uterine endometrioid carcinoma. Am J Surg Pathol. 2013;37:1342–8. https://doi.org/10.1097/PAS.0b013e3182889dc3.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Cohn DE, Mutch DG, Herzog TJ, Rader JS, Dintzis SM, Gersell DJ, Todd CR, Goodfellow PJ. Genotypic and phenotypic progression in endometrial tumorigenesis: determining when defects in DNA mismatch repair and KRAS2 occur. Genes Chromosomes Cancer. 2001;32:295–301.

    Article  CAS  PubMed  Google Scholar 

  25. Han SJ, Kim MK. Clinical significance of mismatch repair genes immunohistochemical expression of complex endometrial hyperplasia. Obstet Gynecol Sci. 2015;58:106–11. https://doi.org/10.5468/ogs.2015.58.2.106.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kohler MF, Nishii H, Humphrey PA, Saski H, Marks J, Bast RC, Clarke-Pearson DL, Boyd J, Berchuck A. Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias. Am J Obstet Gynecol. 1993;169:690–4.

    Article  CAS  PubMed  Google Scholar 

  27. Kurman RJ, Norris HJ. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer. 1982;49:2547–59.

    Article  CAS  PubMed  Google Scholar 

  28. Ambros RA, Sherman ME, Zahn CM, Bitterman P, Kurman RJ. Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol. 1995;26:1260–7.

    Article  CAS  PubMed  Google Scholar 

  29. Soslow RA, Pirog E, Isacson C. Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis. Am J Surg Pathol. 2000;24:726–32.

    Article  CAS  PubMed  Google Scholar 

  30. Tashiro H, Isacson C, Levine R, Kurman RJ, Cho KR, Hedrick L. p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol. 1997;150:177–85.

    PubMed  PubMed Central  CAS  Google Scholar 

  31. Zheng W, Yi X, Fadare O, Liang SX, Martel M, Schwartz PE, Jiang Z. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma. Am J Surg Pathol. 2008;32:304–15.

    Article  PubMed  Google Scholar 

  32. Lee Y, Miron A, Drapkin R, Nucci MR, Medeiros F, Saleemuddin A, Garber J, Birch C, Mou H, Gordon RW, Cramer DW, McKeon FD, Crum CP. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol. 2007;211:26–35.

    Article  CAS  PubMed  Google Scholar 

  33. Jarboe EA, Pizer ES, Miron A, Monte N, Mutter GL, Crum CP. Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma. Mod Pathol. 2009;22:345–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Nguyen TT, Hachisuga T, Urabe R, Kurita T, Kagami S, Kawagoe T, Shimajiri S, Nabeshima K. Significance of p53 expression in background endometrium in endometrial carcinoma. Virchows Arch. 2015;466:695–702.

    Article  CAS  PubMed  Google Scholar 

  35. Zhang X, Liang SX, Jia L, Chen N, Fadare O, Schwartz PE, Kong B, Zheng W. Molecular identification of “latent precancers” for endometrial serous carcinoma in benign-appearing endometrium. Am J Pathol. 2009;174(6):2000.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Zheng W, Liang SX, Yu H, Rutherford T, Chambers SK, Schwartz PE. Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features. Int J Surg Pathol. 2004;12:207–23.

    Article  PubMed  Google Scholar 

  37. Liang SX, Chambers SK, Cheng L, Zhang S, Zhou Y, Zheng W. Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features. Int J Surg Pathol. 2004;12:319–31.

    Article  CAS  PubMed  Google Scholar 

  38. Lax SF, Pizer ES, Ronnett BM, Kurman RJ. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression. Hum Pathol. 1998;29:551–8.

    Article  CAS  PubMed  Google Scholar 

  39. Fadare O, Liang SX, Ulukus EC, Chambers SK, Zheng W. Precursors of endometrial clear cell carcinoma. Am J Surg Pathol. 2006;30:1519–30.

    Article  PubMed  Google Scholar 

  40. Vang R, Barner R, Wheeler DT, et al. Immunohistochemical staining for Ki-67 and p53 helps distinguish endometrial Arias-Stella reaction from high-grade carcinoma, including clear cell carcinoma. Int J Gynecol Pathol. 2004;23:223–33.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Okayama University Hospital, Okayama, Japan

    Hiroyuki Yanai

Authors
  1. Hiroyuki Yanai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroyuki Yanai .

Editor information

Editors and Affiliations

  1. Department of Pathology, Kawasaki Medical School, Kurashiki, Japan

    Takuya Moriya

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Yanai, H. (2018). Heterogeneity of the Precursor Lesions of Endometrial Carcinoma, According to the Histologic Subtype. In: Moriya, T. (eds) Pathology of Female Cancers. Springer, Singapore. https://doi.org/10.1007/978-981-10-8606-9_3

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-8606-9_3

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-8605-2

  • Online ISBN: 978-981-10-8606-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation